Heron Therapeutics Inc (HRTX) Stock Price Today
Aura AI Summary
Key Stats
- $81.83MMARKET_CAP
- -VOLUME
- HealthSECTOR
- $2.23FIFTY_TWO_WEEK_HIGH
- $0.39FIFTY_TWO_WEEK_LOW
- -TYPICAL_HOLD_TIME
- $179.73MENTERPRISE_VALUE
- -DIVIDEND_YIELD
- -TRADING_ACTIVITY
Track Heron Therapeutics Inc (HRTX) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Heron Therapeutics Inc has traded between a low of $0.39 and a high of $2.23, highlighting its annual price range. Buy and sell Heron Therapeutics Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Most Recent News
Transthyretin Amyloidosis Treatment Market to hit $35.1B by 2035, growing at 14.64% CAGR driven by new RNAi therapies and diagnostics.
The global Transthyretin Amyloidosis Treatment Market, valued at $8.95 billion in 2025, is projected to reach $35.10 billion by 2035 with a CAGR of 14.64%. Growth is fueled by advances in gene-silencing RNAi therapies like patisiran and vutrisiran, i...

AI legal drafting tools market to grow from $0.9B in 2025 to $3.42B by 2030, driven by automation and AI advances.
The AI legal drafting tools market is projected to expand rapidly from $0.9 billion in 2025 to $3.42 billion by 2030, with a CAGR of about 30.7%. Growth is fueled by increasing demand for automation in legal processes, adoption of AI-powered contract...

Atos launches MogwAI, a sovereign AI platform for secure, enterprise-grade AI adoption.
Atos has introduced Atos MogwAI, a comprehensive sovereign AI platform designed to help organizations scale AI adoption securely and compliantly. The platform supports end-to-end AI integration, leveraging internal data and processes to create specia...
